Literature DB >> 2980706

Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells.

J M Nesland1, S Lunde, R Holm, J V Johannessen.   

Abstract

Specimens from 7 patients with normal breast tissue 26 patients with benign breast lesions (6 fibroadenomas, and 4 intraductal papillomas, 2 mammae lactantes, 10 cases of cystic disease and 4 fibrotic lesions) were studied by immunocytochemistry and electron microscopy. Excretory epithelial cells in 2 of the 4 papillomas were immunostained for NSE. Myoepithelial cells were frequently stained as well. All the breast specimens were nonreactive to the antichromogranin antibody we used. The 2 NSE positive intraductal papillomas were tested for presence of hormone immunoreactivity, but no positively stained cells were observed. No cells with neuroendocrine features were observed by electron microscopy. The present study did not reveal neuroendocrine cells in the normal breast specimens and undisputed proof of neuroendocrine differentiation in benign breast lesions was not established. We conclude that if neuroendocrine cells are present in the normal breast, they are very rare, and probably not the cellular origin of all breast carcinomas with neuroendocrine features.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2980706

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

1.  Immunoreactive opioid peptides in human breast cancer.

Authors:  L Scopsi; E Balslev; N Brünner; H S Poulsen; J Andersen; F Rank; L I Larsson
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

Review 2.  Primary Neuroendocrine Tumor of the Breast: Current Understanding and Future Perspectives.

Authors:  Hongna Sun; Shuang Dai; Junnan Xu; Linan Liu; Jiaxing Yu; Tao Sun
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

3.  Prognostic importance of neuroendocrine differentiation in Japanese breast cancer patients.

Authors:  Masataka Sawaki; Kazuki Yokoi; Tetsuro Nagasaka; Reiko Watanabe; Chikara Kagawa; Hideki Takada; Shigenori Sato; Tomohiro Yamada; Toyone Kikumori; Tsuneo Imai; Akimasa Nakao
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

Review 4.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer.

Authors:  Maureen A Soh; Scott H Garrett; Seema Somji; Jane R Dunlevy; Xu Dong Zhou; Mary Ann Sens; Chandra S Bathula; Christina Allen; Donald A Sens
Journal:  Cancer Cell Int       Date:  2011-11-18       Impact factor: 5.722

6.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase, creatine kinase and enolase activity and isoenzymes in breast carcinoma.

Authors:  N Durany; J Joseph; O M Jimenez; F Climent; P L Fernández; F Rivera; J Carreras
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.